INTERNATIONAL PATENT: INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FILES APPLICATION FOR "A TUMOR-SPECIFIC NEOANTIGENIC PEPTIDE RESULTING FROM MUTATIONS IN SPLICEOSOME FACTOR 3B SUBUNIT 1"

GENEVA, Jan. 13 -- INSTITUT CURIE (26 rue d'Ulm75005 PARIS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 PARIS) filed a patent application (PCT/EP2025/069230) for "A TUMOR-SPECIFIC NEOANTIGENIC PEPTIDE RESULTING FROM MUTATIONS IN SPLICEOSOME FACTOR 3B SUBUNIT 1" on Jul 04, 2025. With publication no. WO/2026/008882, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LANTZ, Olivier (26 rue d'Ulm75005 PARIS), HOUY, Alexandre (26 rue d'Ulm75005 PARIS), LALANNE, Ana Ines (26 rue d'Ulm75005 ...